Negative signaling in Fc receptor complexes

Cell activation results from the transient displacement of all active balance between positive and negative signaling. This displacement depends in part oil the engagement of cell surface receptors by extracellular ligands. Among these are receptors for the Fc portion of immunoglobulins (FcRs). FcRs are widely expressed by cells of hematopoietic origin. When binding antibodies, FcRs provide these cells with, immunoreceptors capable of triggering numerous biological responses in response to a specific antigen. FcR-dependent cell activation is regulated by negative signals which are generated together with positive signals within signalosomes that form upon FcR engagement. Many molecules involved in positive signaling, including the FcR beta subunit, the src kinase lyn, the cytosolic adapter Grb2, and the transmembrane adapters LAT and. NTAL, are indeed also involved in negative signaling. A major player in negative regulation of FcR signaling is the inositol 5-Phosphatase SHIP1. Several layers of negative regulation operate sequentially (is FcRs are engaged by extracellular ligands with an increasing valency. A background protein tyrosine phosphatase-dependent negative regulation maintains cells in a "restina" state. SHIP1-dependent negative regulation can be detected (is soon (is high-affinity FcRs are occupied by antibodies in the absence of antigen. It increases when activating FcRs are engaged by multivalent ligands and, further, when Fell aggregation increases, accounting for the bell-shaped dose-response curve observed in excess of ligand. Finally, F-actin skeleton-associated high-molecular weight SHIP1, recruited to phosphorylated ITIMs, concentrates in signaling complexes when activating FcRs are coengaged with inhibitory FcRs by immune complexes. Based on these data, activating and inhibitory FcRs could be used for new therapeutic approaches to immune disorders.